InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the complete record of transactions filed by Englese Thomas, Directeur Commercial. Officer active across 1 company, notably Aziyo Biologics, INC.. Aggregated, 4 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €25k. History available since 14 December 2021. The latest transaction was disclosed on 8 March 2023 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Englese Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
937 股0Class A Common StockSEC:0001415889-23-004626:0
15,390 股Class A Common StockSEC:0001415889-22-009538:0
938 股0Class A Common StockSEC:0001415889-22-002868:0
4,580 股@ US$6.10100.0% 占其流量Class A Common StockSEC:0001415889-21-005960:0
标准退出：2022年3月14日 (T+90)
4 条申报中的 4 条
About Englese Thomas
Englese Thomas is the Chief Commercial Officer at AZIYO BIOLOGICS, INC. In this role, he is responsible for commercial strategies and sales development. His expertise in marketing and sales is crucial for the growth and success of Azio.
